Manufacturing

Gain a solid foundation for your manufacturing process, mitigate risks and ensure compliance. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in domestic and overseas manufacturing to exchange ideas on best practice and share case studies on innovation within the area.
 


Untapped Opportunities: Brazil’s Most Promising Regions for Pharma Manufacturing - Paul Samaha

Brazil’s business environment is notoriously cumbersome. The manufacturing sector in particular suffers from high tax rates, poor infrastructure and increasing foreign competition. However, a more in-depth look at this sector reveals several opportunities, particularly for pharma manufacturing. And although new entrants to the market can be initially drawn to the bustling areas around São Paulo and Rio de Janeiro, other regions are now raising the interest of pharma manufacturers. Full Article »


Events related to this topic:

Defining a Criteria for Disposable Solutions in Biomanufacturing - Chris Shaw

In this interview Chris Shaw, CMO at Benchmark Vaccines, discusses the primary criteria for finding a disposable solution for biomanufacturing. Shaw also talks about the industry-wide challenges selecting a disposable solution, such as balancing flexibility and cost. Full Video »


Events related to this topic:

What Pharma can Learn from the Food & Beverage Industry- An Interview with Pepsico's Steve Hills - Gerald Clarke

The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong in working with CMOs Full Podcast »


Events related to this topic:

Creating Effective Leachables and Extractables Testing: Whose Responsibility Is It? - Eric Langer

The problem of leachables and extractables (L&E) in single-use devices continues to hound both suppliers and end-users, and remains one of the more challenging issues inhibiting regulatory acceptance of single-use devices. Full Column »


Events related to this topic:

A-FOOTPRINT: A case study exploring the small steps that are leading to giant strides in the use of additive manufacturing for foot orthoses

The additive manufacturing (AM) revolution is in full swing. The global market for medical applications alone is expected to grow from $355 million in 2012 to almost $1 billion by 2019. The use of AM, or 3-D printing, has been widespread across a number of sectors for the last few years for prototyping and modeling, but real-world commercial opportunities are now beginning to come to the fore as research and development projects identify new uses and techniques. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community